The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and varying degrees of necroinflammation. Although chronic oxidative stress, inflammatory cytokines, and insulin resistance have been implicated in the pathogenesis of NAFLD, the mechanisms that underlie the initiation and progression of this disease remain unknown. c-Jun N-terminal kinase (JNK) is activated by oxidants and cytokines and regulates hepatocellular injury and insulin resistance, suggesting that this kinase may mediate the development of steatohepatitis. The presence and function of JNK activation were therefore examined in the murine methionine- and choline-deficient (MCD) diet model of steatohepatitis. Activation of hepatic JNK, c-Jun, and AP-1 signaling occurred in parallel with the development of steatohepatitis in MCD diet-fed mice. Investigations in jnk1 and jnk2 knockout mice demonstrated that jnk1, but not jnk2, was critical for MCD diet-induced JNK activation. JNK promoted the development of steatohepatitis as MCD diet-fed jnk1 null mice had significantly reduced levels of hepatic triglyceride accumulation, inflammation, lipid peroxidation, liver injury, and apoptosis compared with wild-type and jnk2 -/- mice. Ablation of jnk1 led to an increase in serum adiponectin but had no effect on serum levels of tumor necrosis factor-alpha. In conclusion, JNK1 is responsible for JNK activation that promotes the development of steatohepatitis in the MCD diet model. These findings also provide additional support for the critical mechanistic involvement of JNK1 overactivation in conditions associated with insulin resistance and the metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, activation of JNK was positively related to high fat diet-induced insulin resistance and metabolic syndrome [119], [121], [122], [123].”
In the citing paper
“Furthermore, persistent activation of JNK and/or p38K is positively associated with various liver diseases such as steatohepatitis and I/R injury [122], [123], [124], [125], suggesting the clinical importance of JNK and p38K in human disease states, as reviewed [126].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,312
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 382
Roles of immune dysregulation in MASLD
Dong, T., Li, J., Liu, Y., Zhou, S., Wei, X., Hua, H., Tang, K., Zhang, X., Wang, Y., Wu, Z. F., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116069 · Cited by 43
Feeding trials in organic food quality and health research
Velimirov, A., Huber, M., Lauridsen, C., Rembiałkowska, E., Seidel, K., & Bügel, S. (2009) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.3805 · Cited by 43
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease
Kaser, S., Ebenbichler, C. F., & Tilg, H. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02327.x · Cited by 42
Role of Mitogen-Activated Protein (MAP) Kinase Pathways in Metabolic Diseases
Ng, G. Y. Q., Loh, Z. W.-L., Fann, D. Y., Mallilankaraman, K. B., Arumugam, T. V., & Hande, M. P. (2024) · Genome Integrity · doi:10.14293/genint.14.1.004 · Cited by 49
Kourouma, A., Keita, H., Duan, P., Quan, C., Bilivogui, K. K., Qi, S., Christiane, N. A., Osamuyimen, A., & Yang, K. (2015) · Toxicology Reports · doi:10.1016/j.toxrep.2015.10.006 · Cited by 41
Kassel, K. M., Guo, G. L., Tawfik, O. W., & Luyendyk, J. P. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.143 · Cited by 41
Li, T., Feng, R. M., Zhao, C., Wang, Y., Wang, J., Liu, S., Cao, J., Wang, H., Wang, T., Guo, Y., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6742 · Cited by 41
Jian, T., Ao, X., Wu, Y., Lv, H., Ma, L., Zhao, L., Tong, B., Ren, B., Chen, J., & Li, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.056 · Cited by 41
Alshehade, S. A., Alshawsh, M. A., Murugaiyah, V., Asif, M., Alshehade, O., Almoustafa, H. A., & Zarzour, R. H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120732 · Cited by 42
Pickens, M., Ogata, H., Soon, R. K., Grenert, J. P., & Maher, J. J. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02285.x · Cited by 41
Liu, L., Wang, C., Lee, C., Su, S., Chen, H., Hsu, J.-D., & Lee, H. (2009) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.3821 · Cited by 40
Jung, T. W., Kang, C. M., Goh, J., Chae, S. I., Kim, H., Lee, T. J., El‐Aty, A. M. A., & Jeong, J. H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26449 · Cited by 40
Najjar, S. M., & Russo, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0407-3 · Cited by 40
The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
Zhang, Q., Zhao, L., Tian, X., Yan, C., Li, Y., Liu, Y., Wang, P., Zhang, X., & Han, Y. (2017) · Hepatology · doi:10.1002/hep.29257 · Cited by 38
c-Jun N-terminal kinases as potential therapeutic targets
Salh, B. S. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1339 · Cited by 38
Stremmel, W., Staffer, S., Wannhoff, A., Pathil, A., & Chamulitrat, W. (2014) · The FASEB Journal · doi:10.1096/fj.14-249763 · Cited by 37
Han, C. L., Li, G., Lim, K., DeFrances, M. C., Gandhi, C. R., & Wu, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8027 · Cited by 37
Vinué, Á., Herrero-Cervera, A., & Navarro, H. G. (2018) · Nutrients · doi:10.3390/nu10070939 · Cited by 37
Cao, J., Feng, X., Long, Y., Ning, B., Yang, Z., Fang, D., & Shen, W. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2896-2 · Cited by 36
Nutritional related liver disease: targeting the endoplasmic reticulum stress
Kammoun, H. L., Hainault, I., Ferré, P., & Foufelle, F. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833189db · Cited by 40
Tsuzuki, T., Shinozaki, S., Nakamoto, H., Kaneki, M., Goto, S., Shimokado, K., Kobayashi, H., & Naıto, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132029 · Cited by 35
Min, A.-K., Kim, M. K., Kim, H., Seo, H.-Y., Lee, K.-U., Kim, J., Park, K., & Lee, I. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.012 · Cited by 34
Antioxidative effects ofAlisma orientaleextract in palmitate-induced cellular injury
Han, C. W., Kang, E. S., Ham, S. A., Woo, H. J., Lee, J. H., & Seo, H. G. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.673629 · Cited by 34
Shen, T., Chen, X., Li, Y., Tang, X., Jiang, X., Yu, C., Zheng, Y., Guo, H., & Ling, W. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.027 · Cited by 34
Corrao, S., Natoli, G., & Argano, C. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001684 · Cited by 34
Jian, T., Wu, Y., Ding, X., Lv, H., Ma, L., Zuo, Y., Ren, B., Zhao, L., Tong, B., Chen, J., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.043 · Cited by 33
Guo, C., Han, X., Guo, T., Zhang, W., Xuan, W.-Q., Ren, Y.-T., Wang, D., Chen, Y.-H., Meng, Y., Gao, H., et al. (2020) · Food & Function · doi:10.1039/d0fo00910e · Cited by 33
Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells
Iwaisako, K., Hatano, E., Taura, K., Nakajima, A., Tada, M., Seo, S., Tamaki, N., Sato, F., Ikai, I., Üemoto, S., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.026 · Cited by 33
Wang, Q., Bu, Q., Xu, Z., Liang, Y., Zhou, J., Pan, Y., Zhou, H., & Lü, L. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0107 · Cited by 34
Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis
Andrés‐Blasco, I., Herrero-Cervera, A., Vinué, Á., Martínez‐Hervás, S., Piqueras, L., Sanz, M., Burks, D. J., & Navarro, H. G. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0219 · Cited by 33
Bruschi, F. V., Tardelli, M., Herac, M., Claudel, T., & Trauner, M. (2020) · Liver International · doi:10.1111/liv.14402 · Cited by 33
Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide
Ngoei, K. R. W., Catimel, B., Church, N., Lio, D. S., Dogovski, C., Perugini, M. A., Watt, P. M., Cheng, H.-C., Ng, D. C. H., & Bogoyevitch, M. A. (2011) · Biochemical Journal · doi:10.1042/bj20101244 · Cited by 31
Zhang, N., Lu, Y., Shen, X., Bao, Y., Cheng, J., Chen, L., Bao, L., & Zhang, Q. (2015) · Pharmacology · doi:10.1159/000380952 · Cited by 31
Qiu, B., Lawan, A., Xirouchaki, C. E., Yi, J.-S., Robert, M. E., Zhang, L., Brown, W. A., Fernandez-Hernando, C. F., Yang, X., Tiganis, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41145-5 · Cited by 31
Schattenberg, J. M., Nagel, M. C., Kim, Y. O., Kohl, T., Wörns, M., Zimmermann, T., Schad, A., Longerich, T., Schuppan, D., He, Y.-W., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00525.2011 · Cited by 30
Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis
Mahli, A., Koch, A., Fresse, K., Schiergens, T. S., Thasler, W. E., Schönberger, C., Bergheim, I., Bosserhoff, A., & Hellerbrand, C. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0112-x · Cited by 30
Aghazadeh, S., & Yazdanparast, R. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.08.014 · Cited by 30
How to Protect Against Acetaminophen: Don't Ask for JUNK
Kaplowitz, N., Shinohara, M., Liu, Z., & Han, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.031 · Cited by 30
Human Protein Kinases and Obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_5 · Cited by 29
Cederbaum, A. I., Lu, Y., Wang, X., & Wu, D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_9 · Cited by 29
Li, L., Xia, Y., Ji, X., Wang, H., Zhang, Z., Lu, P., Ding, Q., Wang, D., & Liu, M. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112801 · Cited by 29
INTRACELLULAR SIGNALING BY BILE ACIDS
Anwer, M. (2014) · Journal of Bio-Science · doi:10.3329/jbs.v20i0.17647 · Cited by 28
Sözen, E., Demirel-Yalçıner, T., Sari, D., & Özer, N. K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.024 · Cited by 27
Expression of Hepatic Fat-Specific Protein 27 Depends on the Specific Etiology of Fatty Liver
Aibara, D., Matsusue, K., Matsuo, K., Takiguchi, S., Gonzalez, F. J., & Yamano, S. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00351 · Cited by 27
Iio, A., Ito, M., Itoh, T., Terazawa, R., Fujita, Y., Nozawa, Y., Ohsawa, I., Ohno, K., & Ito, M. (2013) · Medical Gas Research · doi:10.1186/2045-9912-3-6 · Cited by 27
Unfolded Protein Response Sensors in Hepatic Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Henkel, A. S. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1670677 · Cited by 30
Jung, E., Baek, E. B., Hong, E.-J., Kang, J. H., Park, S., Park, S., Hong, E., Cho, Y., Ko, J., Won, Y., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90781 · Cited by 25
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_18 · Cited by 28
Akazawa, Y., & Nakao, K. (2016) · Hepatology Research · doi:10.1111/hepr.12658 · Cited by 25
Who pulls the trigger: JNK activation in liver lipotoxicity?
Ibrahim, S. H., & Gores, G. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.017 · Cited by 25
Magdy, Y., El-Kharashi, O. A., Nabih, E. S., Shaker, S. M., Abd-Elaziz, L. F., & Aboul‐Fotouh, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.098 · Cited by 24
Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies
Jia, F., Hu, X., Kimura, T., & Tanaka, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910303 · Cited by 24
Gehrke, N., Hofmann, L. J., Straub, B. K., Rühle, F., Waisman, A., Galle, P. R., & Schattenberg, J. M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1048 · Cited by 23
Distinct functions of JNK and c‐Jun in oxidant‐induced hepatocyte death
Amir, M., Liu, K., Zhao, E., & Czaja, M. J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24203 · Cited by 24
Animal Models Correlating Immune Cells for the Development of NAFLD/NASH
Iyer, S., Upadhyay, P. K., Majumdar, S. S., & Nagarajan, P. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.06.004 · Cited by 25
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver
Lu, S. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i4.211 · Cited by 24
Free Fatty Acids Shift Insulin-induced Hepatocyte Proliferation towards CD95-dependent Apoptosis
Sommerfeld, A., Reinehr, R., & Häussinger, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617035 · Cited by 24
Nonalcoholic Fatty Liver Disease
Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.014 · Cited by 53
Shi, Y., Ren, J., Zhao, B., Zhu, T., & Qi, H. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07980 · Cited by 24
Protein Kinases in Obesity, and the Kinase-Targeted Therapy
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_7 · Cited by 25
The role of TRIB1 in lipid metabolism; from genetics to pathways
Iwamoto, S., Boonvisut, S., Makishima, S., Ishizuka, Y., Watanabe, K., & Nakayama, K. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150094 · Cited by 24
Musso, G., Gambino, R., Michieli, F. D., Biroli, G., Fagà, E., Pagano, G., & Cassader, M. (2008) · Annals of Medicine · doi:10.1080/07853890801946515 · Cited by 23
Min, R. W. M., Aung, F. W. M., Liu, B., Arya, A., & Win, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082035 · Cited by 22
Kosters, A., White, D., Sun, H., Thevananther, S., & Karpen, S. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.029 · Cited by 22
Jia, X., Naito, H., Yetti, H., Tamada, H., Kitamori, K., Hayashi, Y., Yamagishi, N., Wang, D., Yanagiba, Y., Ito, Y., et al. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.04.029 · Cited by 21
Liu, Q., Rehman, H., Krishnasamy, Y., Schnellmann, R. G., Lemasters, J. J., & Zhong, Z. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.017 · Cited by 22
Kovalic, A. J., Satapathy, S. K., & Chalasani, N. (2018) · Hepatology International · doi:10.1007/s12072-018-9854-1 · Cited by 25
Lee, J. Y., Moon, J. H., Park, J. S., Lee, B., Kang, E. S., Ahn, C. W., Lee, H. C., & Soo, B. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.489 · Cited by 21
Liu, Y., Song, H., Wang, L., Xu, H., Shu, X., Zhang, L. R., Li, Y., Li, D., & Ji, G. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0315-x · Cited by 21
Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway
Lu, S., Natarajan, S. K., Mott, J. L., Kharbanda, K. K., & Harrison-Findik, D. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147474 · Cited by 20
Pierce, A. A., Pickens, M., Siao, K., Grenert, J. P., & Maher, J. J. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0298-y · Cited by 20
Wang, X., Wu, D., Yang, L., & Cederbaum, A. I. (2011) · Hepatology · doi:10.1002/hep.24540 · Cited by 19
Markers in Nonalcoholic Steatohepatitis
Armutçu, F., Akyol, S., Uçar, F., Erdoğan, S., & Akyol, Ö. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-407680-8.00004-x · Cited by 19
Huber, Y., Gehrke, N., Biedenbach, J., Helmig, S., Simon, P. D., Straub, B. K., Bergheim, I., Huber, T., Schuppan, D., Galle, P. R., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.266 · Cited by 19
ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects
Baig, M. H., Baker, A., Ashraf, G. M., & Dong, J.-J. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1676735 · Cited by 19
Litwinowicz, K., Waszczuk, E., & Gamian, A. (2021) · Nutrients · doi:10.3390/nu13103370 · Cited by 20
Li, B., Xiao, Q., Zhang, J., Wang, Y., Liu, J., Zhang, B., & Liu, H. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115769 · Cited by 18
Honey vesicle-like nanoparticles protect aged liver from non-alcoholic steatohepatitis
Liu, B., Nguyen, P. L., Yu, H., Li, X., Wang, H., Nguyen, T. G. B., Sahoo, P. K., Sur, M., Reddy, J., Sillman, S. J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.002 · Cited by 20
EL-Shial, E. M., Kabbash, A. M., El‐Aasr, M., El-Feky, O. A., & El-Sherbeni, S. A. (2023) · Molecules · doi:10.3390/molecules28020879 · Cited by 17
Yu, F., Chen, Y., Yang, B., Lan, Q., Wang, T., Cui, G., Ren, Z., Choi, I. C., Leung, G., Yan, F., et al. (2019) · BioMed Research International · doi:10.1155/2019/7465272 · Cited by 17
Zhang, Y., Zhou, G., Chen, Z., Guan, W., Zhang, J., Bi, M., Wang, F., You, X., Liao, Y., Zheng, S., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8786424 · Cited by 20
Zhang, M., Tu, W. J., Zhang, Q., Wu, X. L., Zou, X., & Jiang, S. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102026 · Cited by 17
Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD
Ezhilarasan, D., & Kulanthaivel, L. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4112 · Cited by 17
Gehrke, N., Garcia-Bardon, D., Mann, A., Schad, A., Alt, Y., Wörns, M. A., Sprinzl, M. F., Zimmermann, T., Menke, J., Engstler, A. J., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.178 · Cited by 15
Olivares, S., Green, R. M., & Henkel, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103828 · Cited by 15
Vallée, D., Blanc, M., Lebeaupin, C., & Bailly‐Maitre, B. (2020) · médecine/sciences · doi:10.1051/medsci/2020008 · Cited by 16
Sanhueza, S., Tobar, N., Cifuentes, M., Quenti, D., Varı́, R., Scazzocchio, B., Masella, R., Herrera, K., Paredes, A., Morales, G., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00811-8 · Cited by 15
Nonalcoholic Fatty Liver Disease
Patel, V. A., & Sanyal, A. J. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_23 · Cited by 15
Effects of altered hepatic lipid metabolism on regulation of hepatic iNOS
Stanimirović, J., Obradovic, M. M., Zafirovic, S. S., Resanović, I., Bogdanović, N., Gluvic, Z. M., Mousa, S. A., & Isenović, E. R. (2015) · Clinical Lipidology · doi:10.2217/clp.15.8 · Cited by 14
Govaere, O., Petersen, S. K., Martínez-López, N., Wouters, J., Haele, M. V., Mancina, R. M., Jamialahmadi, O., Bilkei‐Gorzo, O., Lassen, P. B., Darlay, R., et al. (2020) · Journal of Hepatology · doi:10.1016/s0168-8278(20)30598-5 · Cited by 14
Gan, C., Wang, J., Wang, Y., Martínez-Chávez, A., Hillebrand, M. J. X., de Vries, N., Beukers, J., Lebre, M. C., Wagenaar, E., Rosing, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114956 · Cited by 13
Nonalcoholic Steatohepatitis Promoting Kinases
Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1713115 · Cited by 13
Nicholls, H. T., Hornick, J. L., & Cohen, D. E. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00379.2016 · Cited by 13
Nonalcoholic steatohepatitis: Pathogenesis and treatment
Park, S. H. (2008) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2008.14.1.12 · Cited by 13
ROS: Redux and paradox in fatty liver disease
Tsedensodnom, O., & Sadler, K. C. (2013) · Hepatology · doi:10.1002/hep.26497 · Cited by 13
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease
Pan, Q., Fan, J., & Yilmaz, Y. N. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.013 · Cited by 14
Srivastava, S., Li, Z., Yang, X., Yedwabnick, M. J., Shaw, S. M., & Chan, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-364 · Cited by 12
Radwan, M. M., Radwan, B. M., Nandipati, K. C., Hunter, W. J., & Agrawal, D. K. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.816484 · Cited by 11
RETRACTED: c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity
Serna, R., Ramrakhiani, A., Hernandez, J. C., Chen, C., Nakagawa, C., Machida, T., Ray, R. B., Zhan, X., Tahara, S. M., & Machida, K. (2022) · iScience · doi:10.1016/j.isci.2022.104325 · Cited by 10
RetractedCommon Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Giannopoulos, C., Tzima, I. G., Tentolouris, N., & Vasileiadis, I. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230216112032 · Cited by 12
Metadata
- Authors
- Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J.
- Affiliations
- Albert Einstein College of Medicine (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Czaja, Mark J.
- Venue
- Hepatology
- Published
- 2006-01
- Volume
- 43
- Issue
- 1
- Pages
- 163-172
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2108678340
- Cited by
- 384
- References
- 43
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 14 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 18 · 2019: 11 · 2018: 14 · 2017: 21 · 2016: 18 · 2015: 20 · 2014: 29 · 2013: 24 · 2012: 26
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-61498, DK 55758, R01DK055758, R01DK061498)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- JNK1, JNK2, non-alcoholic fatty liver disease, steatohepatitis, methionine-choline-deficient diet, hepatic steatosis, c-Jun, AP-1 signaling, lipid peroxidation, liver inflammation, insulin resistance, adiponectin, TNF-α, apoptosis, knockout mice
- MeSH terms
- Alanine Transaminase, Animals, Choline Deficiency, Enzyme Activation, Fatty Liver, Female, Liver, Male, Methionine, Mice, Inbred C57BL, Triglycerides, Lipid Peroxidation, Apoptosis, Intercellular Adhesion Molecule-1, Mitogen-Activated Protein Kinase 8, Mitogen-Activated Protein Kinase 9, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review